Literature DB >> 15750135

Spondylitis due to Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literature.

Agnès Meybeck1, Claude Fortin, Sophie Abgrall, Homa Adle-Biassette, Gilles Hayem, Raymond Ruimy, Patrick Yeni.   

Abstract

Nontuberculous mycobacterial infections are well known to occur in patients with human immunodeficiency virus infection. However, spondylitis due to mycobacteria other than Mycobacterium tuberculosis is uncommon. We report a case of biopsy- and culture-proven Mycobacterium xenopi spondylitis in an AIDS patient and discuss approaches to diagnosis and therapy. This case serves to highlight the potential pathogenic role of this usually environmental commensal organism in severely immunosuppressed AIDS patients and uncertainties in their management, given the scarce data on appropriate therapy for this organism.

Entities:  

Mesh:

Year:  2005        PMID: 15750135      PMCID: PMC1081249          DOI: 10.1128/JCM.43.3.1465-1466.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  A step forward in the evidence-based treatment of opportunist mycobacteria.

Authors:  P Ormerod
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man.

Authors:  H SCHWABACHER
Journal:  J Hyg (Lond)       Date:  1959-03

Review 3.  Mycobacterium xenopi infection of the spine: a case report and literature review.

Authors:  T Danesh-Clough; J C Theis; A van der Linden
Journal:  Spine (Phila Pa 1976)       Date:  2000-03-01       Impact factor: 3.468

4.  Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak.

Authors:  P Astagneau; N Desplaces; V Vincent; V Chicheportiche; A Botherel; S Maugat; K Lebascle; P Léonard; J Desenclos; J Grosset; J Ziza; G Brücker
Journal:  Lancet       Date:  2001-09-01       Impact factor: 79.321

5.  Mycobacterium xenopi osteomyelitis in a patient on highly active antiretroviral therapy (HAART).

Authors:  R Kulasegaram; D Richardson; B Macrae; A de Ruiter
Journal:  Int J STD AIDS       Date:  2001-06       Impact factor: 1.359

6.  First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

7.  Role of Mycobacterium xenopi disease in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Comparison with the pre-Haart period.

Authors:  Roberto Manfredi; Anna Nanetti; Marina Tadolini; Leonardo Calza; Samanta Morelli; Morena Ferri; Ginevra Marinacci
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

8.  Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?

Authors:  L Kerbiriou; A Ustianowski; M A Johnson; S H Gillespie; R F Miller; M C I Lipman
Journal:  Clin Infect Dis       Date:  2003-10-07       Impact factor: 9.079

9.  Spinal infection with Mycobacterium xenopi.

Authors:  A J Prosser
Journal:  Tubercle       Date:  1986-09

10.  Spinal infection by Mycobacterium xenopi in a non-immunosuppressed patient.

Authors:  M A Rahman; V Phongsathorn; T Hughes; C Bielawska
Journal:  Tuber Lung Dis       Date:  1992-12
View more
  4 in total

Review 1.  Prosthetic joint infection due to Mycobacterium xenopi: a review of the literature with a new case report.

Authors:  Paola Rodari; Stefania Marocco; Dora Buonfrate; Anna Beltrame; Chiara Piubelli; Pierantonio Orza; Veronica Andrea Fittipaldo; Zeno Bisoffi
Journal:  Infection       Date:  2019-05-16       Impact factor: 3.553

2.  Pleuritis due to Mycobacterium xenopi without pulmonary infection.

Authors:  Keren Bachar; Tiberiu Shulimzon; Efrat Ofek; Michael J Segel
Journal:  Access Microbiol       Date:  2022-03-22

3.  Multilocus sequence typing of Mycobacterium xenopi.

Authors:  David C Alexander; Theodore K Marras; Jennifer H Ma; Samia Mirza; Daniel Liu; Julianne V Kus; Hafid Soualhine; Vincent Escuyer; David Warshauer; Sarah K Brode; David J Farrell; Frances B Jamieson
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

4.  Mycobacterium xenopi clinical relevance and determinants, the Netherlands.

Authors:  Jakko van Ingen; Martin J Boeree; Wiel C M de Lange; Wouter Hoefsloot; Saar A Bendien; Cecile Magis-Escurra; Richard Dekhuijzen; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.